Abstract
Both case reports and small controlled studies suggest the efficacy of verapamil in the treatment of mania. Forty patients with DSM-IV mania were studied in a 28-day randomized, controlled, single-blind trial of either lithium or verapamil. The patients receiving lithium showed a significant improvement on all rating scales (Brief Psychiatric Rating Scale [BPRS], Mania Rating Scale [MRS], Global Assessment of Functioning [GAF], and Clinical Global Impression [CGI]) compared with those receiving verapamil. The mean MRS score at Day 28 in the lithium group was significantly lower than that in the verapamil group (17.47 vs. 24.43, respectively; F = 6.17, df = 1, p = .018). A similar pattern was seen with the BPRS (12.68 vs. 20.57; F = 10.69, df = 1, p = .002), CGI (2.31 vs. 3.33; F = 6.05, df = 1, p = .019), and GAF (43.52 vs. 52.31; F = 4.36, df = 1, p = .044) (ANCOVA). This study suggests that lithium is superior to verapamil in the management of acute mania.
Citations
Apr 25, 2000·Journal of Clinical Psychology·R H MoosB S Moos
Dec 21, 2000·Journal of Affective Disorders·P E KeckC Carbonell
Mar 4, 2000·Psychiatry Research·A J GianniniM Condon
Jun 10, 2000·Journal of Clinical Pharmacy and Therapeutics·N PoolsupI R de Oliveira
Oct 28, 2005·Telemedicine Journal and E-health : the Official Journal of the American Telemedicine Association·Brian J Grady, Ted Melcer
Mar 7, 2003·Cardiology in Review·Seth Keller, William H Frishman
Apr 3, 2001·Bulletin of the Menninger Clinic·M J Gitlin
Jul 20, 2002·Clinical Pharmacokinetics·Beth Sproule
Jan 5, 2002·CNS Drugs·Per Bech
Apr 3, 2001·Expert Opinion on Investigational Drugs·C L Bowden
Jun 5, 2003·Bipolar Disorders·Mukund GnanadesikanAlan J Gelenberg
Oct 5, 2010·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Francesco CasamassimaRoy H Perlis
May 2, 2002·Biological Psychiatry·Katherine L WisnerSusan Baab
May 27, 2014·Journal of Affective Disorders·Steven L DubovskyKenneth E Leonard
Feb 5, 2010·The International Journal of Neuropsychopharmacology·Jorge M TamayoMauricio Tohen
Dec 1, 2003·Acta Neuropsychiatrica·M Berk, G S Malhi
Nov 29, 2002·Human Psychopharmacology·Gin S Malhi, Michael Berk
Mar 17, 2001·Bipolar Disorders·N A Levy, P G Janicak
Apr 7, 2009·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeSiegfried Kasper
Oct 2, 2003·Journal of Clinical Psychopharmacology·Terence A KetterRobert M Post
Jan 1, 2011·Journal of Central Nervous System Disease·Rif S El-MallakhR Jeannie Roberts
Dec 19, 2018·Expert Opinion on Drug Metabolism & Toxicology·Steven L Dubovsky
Jul 21, 1998·Acta Psychiatrica Scandinavica·R W Licht
Jan 25, 2006·Molecular Psychiatry·M Gitlin
Jan 1, 2008·International Journal of Psychiatry in Clinical Practice·Gurvinder Pal Singh
Oct 28, 1998·Journal of Clinical Psychopharmacology·P J PazzagliaD Luckenbaugh
Feb 24, 2004·CNS Spectrums·Paul E Holtzheimer, John F Neumaier
Sep 29, 1999·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·L E Hollister, E S Trevino
Nov 4, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeUNKNOWN Members of the WFSBP Task Force on Bipolar Affective Disorders Working on this topic